Initial experience with 223Ra-dichloride treatment

被引：0
|
作者：
Yepes Agudelo, A. M. [1 ]
Bello Arques, P. [1 ]
Borrelli, P. [1 ]
Olivan Sasot, P. [1 ]
Vera Pinto, V. [1 ]
机构：
[1] HUP La Fe, Valencia, Spain
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2016年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP512
引用
收藏
页码：S424 / S425
页数：2
相关论文
共 50 条
  • [21] Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting 223Ra-dichloride
    Massimiliano Pacilio
    Guido Ventroni
    Giuseppe De Vincentis
    Bartolomeo Cassano
    Rosanna Pellegrini
    Elisabetta Di Castro
    Viviana Frantellizzi
    Giulia Anna Follacchio
    Tatiana Garkavaya
    Leda Lorenzon
    Pasquale Ialongo
    Roberto Pani
    Lucio Mango
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 21 - 33
  • [22] Baseline quality of life predicts overall survival in patients with mCRPC treated with 223Ra-dichloride
    Frantellizzi, Viviana
    De Feo, Maria Silvia
    Di Rocco, Arianna
    Pontico, Mariano
    Pani, Arianna
    Farcomeni, Alessio
    Cosma, Laura
    Lazri, Julia
    De Vincentis, Giuseppe
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2020, 23 (01): : 12 - 20
  • [23] Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting 223Ra-dichloride
    Pacilio, Massimiliano
    Ventroni, Guido
    De Vincentis, Giuseppe
    Cassano, Bartolomeo
    Pellegrini, Rosanna
    Di Castro, Elisabetta
    Frantellizzi, Viviana
    Follacchio, Giulia Anna
    Garkavaya, Tatiana
    Lorenzon, Leda
    Ialongo, Pasquale
    Pani, Roberto
    Mango, Lucio
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (01) : 21 - 33
  • [24] Feasibility and efficacy of 223Ra-dichloride in treatment of bone metastases in patients with castration-refractory prostate cancer (mCRPC)
    Mazzarri, S.
    Boni, G.
    Borso, E.
    Galli, L.
    Farnesi, A.
    Betti, F.
    Antonacci, L.
    Traino, A.
    Ricci, S.
    Volterrani, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S57 - S58
  • [25] Two Years Of Experience Of 223Ra-Dichloride In Clinical Practice: Have We Started Treating At Earlier Stage Of Bone Disease?
    Dizdarevic, S.
    Jessop, M.
    Begley, P.
    Aplin, M.
    Hosur, A.
    Nikapota, A.
    Robinson, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S102 - S102
  • [26] Feasibility and efficacy of 223Ra-dichloride (223Ra) to treat bone metastases in patients (pts) with castration resistant prostate cancer (mCRPC)
    Farnesi, A.
    Mazzarri, S.
    Boni, G.
    Galli, L.
    Cianci, C.
    Borso', E.
    Marconcini, R.
    Biasco, E.
    Derosa, L.
    Sbrana, A.
    Antonuzzo, A.
    Ricci, S.
    Volterrani, D.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2015, 26 : 62 - 62
  • [27] The potential of 223Ra and 18F-fluoride imaging to predict bone lesion response to treatment with 223Ra-dichloride in castration-resistant prostate cancer
    Murray, Iain
    Chittenden, Sarah J.
    Denis-Bacelar, Ana M.
    Hindorf, Cecilia
    Parker, Christopher C.
    Chua, Sue
    Flux, Glenn D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (11) : 1832 - 1844
  • [28] The potential of 223Ra and 18F-fluoride imaging to predict bone lesion response to treatment with 223Ra-dichloride in castration-resistant prostate cancer
    Iain Murray
    Sarah J. Chittenden
    Ana M. Denis-Bacelar
    Cecilia Hindorf
    Christopher C. Parker
    Sue Chua
    Glenn D. Flux
    European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 1832 - 1844
  • [29] Use Of 223Ra-dichloride In Mcrpc Patients At The Early Onset Of Castration Resistance: Is Early Introduction Useful?
    Frantellizzi, V.
    De Feo, M. S.
    Lazri, J.
    Cosma, L.
    De Vincentis, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S236 - S236
  • [30] Benefit of 68Ga-PSMA-PET/CT in Patients Considered for 223Ra-Dichloride Therapy
    Bode, Axel
    Rahbar, Kambiz
    Konnert, Julia
    Boegemann, Martin
    Stegger, Lars
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (12) : 951 - 952
12345